Fortress Biotech, Inc.
Home
About
Overview
Business Development
Management Team
Board of Directors
FAQ
Programs
Pipeline
Marketed Products
Publications
News & Media
Press Releases
Presentations
Events
Investors
Overview
News / Events
Company Info
Financial Info
Stock Data
Analyst Coverage
SEC Filings
Governance
Resources
Contact
Careers
FAQ
Accessibility Statement
All SEC Filings
Investors
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Special Meeting Materials
Annual Meeting Materials
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Resources
FBIOP Announcements
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Special Meeting Materials
Annual Meeting Materials
Filing Type:
View All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
PRE 14A
PX14A6G
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Date
Form
Description
PDF
XBRL
Pages
07/09/19
4/A
Statement of changes in beneficial ownership of securities
2
06/28/19
S-3/A
Registration statement for specified transactions by certain issuers
Documents
EX-1.1
EX-5.1
EX-5.2
EX-23.1
96
06/20/19
8-K
Current report filing
4
05/17/19
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
7
05/10/19
8-K
Current report filing
Documents
EX-99.1
9
05/10/19
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
195
04/30/19
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
5
04/30/19
DEF 14A
Definitive proxy statements
45
04/19/19
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
7
04/19/19
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
8
Previous
30
31
32
33
34
35
36
37
38
39
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed